Nicotinamide Riboside in SARS-CoV-2 (COVID-19) Patients for Renal Protection
Conditions
- SARS-CoV-2 Infection
- Acute Kidney Injury
Interventions
- DRUG: Placebo
- DRUG: Nicotinamide riboside
Sponsor
The University of Texas Health Science Center at San Antonio
Collaborators